首页> 美国卫生研究院文献>Natural Products and Bioprospecting >In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
【2h】

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

机译:通过药理学模型和分子对接在计算机上发现新型FXa抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractCoagulation Factor Xa (FXa) is the crucial enzyme at the convergent point of the intrinsic and extrinsic coagulation pathways. The inhibition of FXa is an effective approach against thrombotic diseases. In the present study, a specific strategy is reported to discover 10 novel FXa inhibitors based on ligand-based (pharmacophore) virtual screening and molecular docking analysis from a dataset of specs(containing 220000 molecules). The binding modes analysis provide insights into the contribution of particular structural moieties of the compounds towards their activity against FXa, and 10 novel structural compounds were discovered as potent candidate molecules. This work could be helpful in further design and development of FXa inhibitors.
机译:摘要凝血因子Xa(FXa)是内在和外在凝血途径交汇处的关键酶。抑制FXa是抗血栓形成疾病的有效方法。在本研究中,报告了一种特殊的策略,该方法可从规格数据集中(包含220000个分子)基于配体基(药效团)虚拟筛选和分子对接分析发现10种新型FXa抑制剂。结合模式分析提供了对化合物的特定结构部分对其抗FXa活性的贡献的见解,并发现了10种新型结构化合物作为有效的候选分子。这项工作可能有助于进一步设计和开发FXa抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号